Tinnitus and Cochlear Implants
Launched by UNIVERSITY OF NOTTINGHAM · Oct 12, 2023
Trial Information
Current as of September 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Primary objective:
Determine whether there are meaningful changes in tinnitus outcomes following cochlear implantation in adults with bilateral severe-to-profound hearing loss.
Secondary objectives:
1. Determine the prevalence, nature, and severity of tinnitus before cochlear implantation.
2. Determine the incidence, nature, and changes in severity of tinnitus following cochlear implantation.
3. Explore associations between tinnitus and changes in hearing, psychological health, cochlear implantation-related factors, and quality of life in cochlear implant recipients with and without tinn...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older.
- • Determined to be eligible for unilateral cochlear implantation.
- • Did not previously receive a cochlear implant in either ear.
- • Sufficient written or spoken English to participate in study activities.
- • Have access to internet or suitable device to complete online study questionnaires.
- • Able to give informed consent.
- Exclusion Criteria:
- • Significant difficulties preventing independent completion of study activities.
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, Nottinghamshire, United Kingdom
Patients applied
Trial Officials
Derek J Hoare, PhD
Principal Investigator
University of Nottingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported